TY  - GEN
AU  - Chiang,Chi-Ling
AU  - Goswami,Swagata
AU  - Frissora,Frank W
AU  - Xie,Zhiliang
AU  - Yan,Pearlly S
AU  - Bundschuh,Ralf
AU  - Walker,Logan A
AU  - Huang,Xiaomeng
AU  - Mani,Rajeswaran
AU  - Mo,Xiaokui M
AU  - Baskar,Sivasubramanian
AU  - Rader,Christoph
AU  - Phelps,Mitch A
AU  - Marcucci,Guido
AU  - Byrd,John C
AU  - Lee,L James
AU  - Muthusamy,Natarajan
TI  - ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model
SN  - 1528-0020
PY  - 2020///0113
KW  - Animals
KW  - Biomarkers, Tumor
KW  - Cell Cycle Checkpoints
KW  - genetics
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - drug effects
KW  - DNA Methylation
KW  - Disease Models, Animal
KW  - Epigenesis, Genetic
KW  - Humans
KW  - Immunoconjugates
KW  - administration & dosage
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - drug therapy
KW  - Mice
KW  - MicroRNAs
KW  - Nanoparticles
KW  - Receptor Tyrosine Kinase-like Orphan Receptors
KW  - antagonists & inhibitors
KW  - Survival Rate
KW  - Theranostic Nanomedicine
KW  - Treatment Outcome
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1182/blood.2018882290
ER  -